by Sue Robbins | Jun 3, 2020 | Migraine
There’s no mistaking a migraine headache — the excruciating head pain, nausea and sensitivity to light and sound. The incapacitating attacks can last for hours or days and are sometimes frequent enough to cause moderate or severe disability. “Fortunately, the list of...
by Sue Robbins | May 22, 2020 | Migraine
Insufficient response to triptans is associated with poor health-related quality of life (HRQoL) and lower work productivity in migraineurs compared with those who respond well to the medications, according to a study published in The Journal of Headache and Pain....
by Sue Robbins | Apr 27, 2020 | Migraine
Despite significant burden and symptoms, many individuals with migraine have never used acute prescription pain medication to treat the condition, according to study results published in Mayo Clinic Proceedings. The Chronic Migraine Epidemiology and Outcomes study, an...
by Sue Robbins | Nov 8, 2019 | Migraine
Eli Lilly, Allergan and Biohaven have a lot riding on their forthcoming migraine launches, and now cost-effectiveness watchdog ICER has come out with some less-than-stellar findings from data supporting the drugs. The Institute for Clinical and Economic...
by Sue Robbins | Oct 6, 2019 | Migraine
Tosymra (sumatriptan; Upsher Smith Laboratories) nasal spray is now available for the acute treatment of migraine with or without aura in adults. Read more here.
